Clinical Trial to Evaluate the Effect of an Oral Probiotic on the Vaginal Flora

Clinical Trial to Evaluate the Effect of an Oral Probiotic (Food Supplement) Containing Lactobacillus Crispatus on the Vaginal Flora

Clinical trial to evaluate the effect of a probiotic containing Lactobacillus Crispatus on the vaginal flora

Inclusion Criteria:

• Healthy women between 18 and 45 years old
• Women without current symptoms of vaginal infection
• Negative bacteriological and clinical examination

Exclusion Criteria:

• Women with vaginal infection
• Women with undiagnosed vaginal bleeding
• Patients with endometrial hyperplasia
• Suspicion of neoplasia or active neoplasia
• Women with intolerance, allergy or hypersensitivity to the components of the probiotic
• Women with immunosuppressive disorders or with HIV
• Women who are currently using probiotics by any route of administration
• Women who are using some treatment for vaginal sepsis
• Chronic decompensated noncommunicable diseases (diabetes mellitus, heart disease ...)
• Pregnant women or those with precocious menopause